According to the latest disclosure from the Hong Kong Stock Exchange, BlackRock increased its shareholding in INNOVENT BIO (01801) on August 12, acquiring 139,500 shares at a price of HKD 95.375 per share.
The total transaction value amounted to approximately HKD 13.30 million. Following this purchase, BlackRock's latest shareholding count stands at approximately 87.32 million shares, representing a 5.01% stake in the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.